NetworkNewsBreaks

TuesdayJan 02, 2018 11:10 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Provides Post-Holiday Update on Baijiu Sales

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning offered shareholders a post-holiday update on CBD Biotechnology Co. Ltd.’s Yantai 1985 baijiu sales. Through a partnership with a proven leader in the Chinese baijiu market, the company’s wholly-owned foreign enterprise has commenced an initial marketing campaign on Chinese mobile app Today’s Headlines that it anticipates will drive revenues of approximately $1.8 million in 2018. These projections are supported by the early success of CBD Biotechnology’s advertising efforts. Notably, the digital ad campaign generated revenues of over $29,000 in its first week. “The marketing-to-revenue ratio for the initial sales campaign on…

Continue Reading

TuesdayJan 02, 2018 10:31 am

NetworkNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Receives Cannabis Oil Production License from Health Canada

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has been licensed by Health Canada to produce medical cannabis oils. Per the update, Health Canada will conduct a final inspection when ABcann has saleable extracted finished products. ABcann expects to complete this process in the first quarter of 2018. “Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed,” Barry Fishman, CEO of ABcann, stated in the news release. “The expansion and innovation of our product lines…

Continue Reading

TuesdayJan 02, 2018 9:43 am

NetworkNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Adds Dr. Brian O’Connor to Advisory Board

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning announced the addition of Dr. Brian O’Connor, a consultant in respiratory medicine, to its advisory board. Per the update, O’Connor is a clinical expert in the areas of asthma, chronic obstructive pulmonary disease (“COPD”), allergic disease and lung cancer. He is also an active clinical researcher committed to investigating new treatment strategies in airways disease. “Dr. O’Connor brings a great reputation of clinical excellence and scholarly research,” Dr. Lui Franciosi, CEO of Veritas, stated in the news release. “He will advise us on…

Continue Reading

TuesdayJan 02, 2018 9:05 am

NetworkNewsBreaks – MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) Completes Site Survey at Paradox Basin Petrolithium Project

Diversified resource and technology company MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) this morning announced that the site survey at its Paradox Basin Petrolithium Project has been completed, clearing the way for 3D seismic geophysics. Per the update, the purpose of the geophysical survey, which includes data from roughly 9,000 source points, is to outline subsurface geological formations and structures that are favorable for accumulations of oil and gas, as well as lithium brine bearing formations. The surveyed Blueberry Unit consists of over 80,000 acres of federal, state and private land, the overwhelming majority of which are currently…

Continue Reading

FridayDec 29, 2017 12:05 pm

NetworkNewsBreaks – Skinvisible, Inc. (SKVI) Prepares to Address Killer Drug Epidemic Through Proposed Merger Agreement

Topical and transdermal product development company Skinvisible (OTCQB: SKVI) recently signed a letter of intent regarding a proposed merger with Quoin Pharmaceuticals Limited. The two companies intend to work together to address the opioid epidemic plaguing America. An article discussing this reads: “There are increased incentives and growing public and FDA/government demands to address the crisis. Innovators vying to meet critical needs and to combat the opioid issue with alternative, non-addictive and effective products include Skinvisible, Inc. (OTCQB: SKVI) and Quoin Pharmaceuticals Limited. As announced earlier this month, the two companies have entered a Letter of Intent for a proposed…

Continue Reading

FridayDec 29, 2017 11:57 am

NetworkNewsBreaks – Marijuana Company of America, Inc. (MCOA) Positioned for Bright Future Amid Support from Recognized Health Organization

With a portfolio of operating subsidiaries, partnerships and joint ventures, Marijuana Company of America (OTC: MCOA) is slated to exploit the ever-growing cannabis market as support of the industry continues to grow among recognized health organizations. An article discussing this reads: “The World Health Organization (“WHO”) officially recommended on December 14, 2017, that the chemical compound cannabidiol (CBD) no longer be internationally scheduled as a controlled substance. WHO has issued a preliminary report that found CBD to be non-addictive and generally safe. ... The wholly-owned subsidiary of Marijuana Company of America Inc. (OTC: MCOA), hempSMART™, Inc. is an affiliate marketing…

Continue Reading

FridayDec 29, 2017 11:50 am

NetworkNewsBreaks – New Heights in Cobalt Price Spurs Investor Interest in Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B)

Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) and other mineral exploration companies are working to take advantage of the surge in cobalt’s spot price during 2017 to a nine-year high, with a 120 percent rise during the year reported and predictions that demand will continue in 2018 to fuel technology-friendly markets. An article discussing this reads: “Well-aware of the shifting supply scene, Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) is focusing its attention on developing its mining interests in Canada (http://nnw.fm/0uPqp), where the company owns three properties tucked into the core of Ontario’s cobalt belt. Quantum earlier this week announced…

Continue Reading

FridayDec 29, 2017 9:44 am

NetworkNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Visits Clinical Trial Facility in San Juan, Puerto Rico

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning announced that it has completed a prestudy visit of the Fundación de Investigación (“FDI”) facilities in San Juan, Puerto Rico. Per the release, this will be the site where the company’s research arm, Cannevert Therapeutics Ltd. (“CTL”), will be conducting its first human study of CTL-X, a cannabis strain targeting the pain management market. Speaking about the FDI clinical trial facility in this morning's update, Veritas CEO Lui Franciosi stated, “I was very impressed by their Phase I and Phase II-III clinical trial…

Continue Reading

ThursdayDec 28, 2017 12:42 pm

NetworkNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Entry into Biopharmaceutical Industry Focus of Zacks Small Cap Research Article

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the global life sciences industry, was recently the focus of a publication by Zacks Small Cap Research titled “PBIO: Enters Biopharmaceutical Quality Control Market”. The publication follows the company’s December 20 announcement regarding the release of redesigned software for its Barocycler 2320EXTREME instrument. The publication notes that the new software was created through collaboration with the company’s biopharmaceutical company customers, therefore entering PBIO into the biopharmaceutical market and accelerating the company’s revenue growth.  The Zacks report also discusses PBIO recently acquiring all assets of BaroFold,…

Continue Reading

ThursdayDec 28, 2017 11:41 am

NetworkNewsBreaks – Petrogress, Inc. (PGAS) Finds New Life in Oil Shipping Markets

Petrogress, Inc. (OTC: PGAS) continues to build a diversified revenue stream through its oil and gas shipping networks as it expands its operations along Africa’s west coast, in the Mediterranean region, Europe and the United States. The company is working to purchase more tankers, complete exploration and refinery talks in Ghana, and finalize negotiations on an operations and management pact in Hellenic Cyprus. An article discussing this reads: “Despite a recent slump in African crude oil sales (http://nnw.fm/1kFgc) and the comparable effect on the company’s sales volume revenues and gross profits, Petrogress reported a rise in profitability from 3.82 percent…

Continue Reading